Class 4 Caution in Use
Aspar Pharmaceuticals Limited has informed us that the Patient Information Leaflets (PILs) within the ibuprofen packs below are missing some information identified from post-marketing experience that should be documented in Section 3 (How To Take The Tablets) and Section 4 (Possible Side Effects) of the PIL.
Please visit the: MHRA website for more details on this drug alert.
The affected products' details are as follows:
PIP Code | Product Description | Livery | Affected Batch |
---|---|---|---|
6835151 | IBUPROFEN TAB 200MG | ASPAR PHARMACEUTICALS | Please refer to link above |
6835169 | IBUPROFEN TAB 200MG | ASPAR PHARMACEUTICALS | Please refer to link above |
1000132 | IBUPROFEN TAB 200MG | ASPAR PHARMACEUTICALS | Please refer to link above |
1038892 | IBUPROFEN TAB 200MG | ASPAR PHARMACEUTICALS | Please refer to link above |
1077601 | IBUPROFEN TAB 200MG | ASPAR PHARMACEUTICALS | Please refer to link above |
1187509 | IBUPROFEN TAB 400MG | ASPAR PHARMACEUTICALS | Please refer to link above |
6835177 | IBUPROFEN TAB 400MG | ASPAR PHARMACEUTICALS | Please refer to link above |
6835185 | IBUPROFEN TAB 400MG | ASPAR PHARMACEUTICALS | Please refer to link above |
1058262 | IBUPROFEN TAB 400MG | ASPAR PHARMACEUTICALS | Please refer to link above |
1130509 | IBUPROFEN TAB 400MG | ASPAR PHARMACEUTICALS | Please refer to link above |
1130491 | IBUPROFEN TAB 400MG | ASPAR PHARMACEUTICALS | Please refer to link above |
Recipients of this Drug Alert should bring it to the attention of relevant contacts.
This is a caution in use only and therefore we are not accepting stock returns.
If you have any questions, then please contact your local Service Centre Customer Services team.